503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-6.44%
Negative net income growth while ORCL stands at 12.47%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
30.75%
D&A growth well above ORCL's 2.18%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-9.57%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
15.78%
SBC growth well above ORCL's 21.20%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-652.43%
Both reduce yoy usage, with ORCL at -203.76%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-126.98%
Both yoy AR lines negative, with ORCL at -132.19%. Martin Whitman would suspect an overall sector lean approach or softer demand.
340.33%
Inventory growth of 340.33% while ORCL is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-31.33%
Both negative yoy AP, with ORCL at -272.89%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-120.81%
Both reduce yoy usage, with ORCL at -192.67%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
103.76%
Some yoy increase while ORCL is negative at -14.74%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-51.84%
Both yoy CFO lines are negative, with ORCL at -86.72%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
0.14%
Some CapEx rise while ORCL is negative at -41.65%. John Neff would see competitor possibly building capacity while we hold back expansions.
-94.56%
Negative yoy acquisition while ORCL stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-131.38%
Both yoy lines negative, with ORCL at -857.89%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
24.86%
Below 50% of ORCL's 134.78%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
65.00%
We have some outflow growth while ORCL is negative at -374.07%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-128.29%
We reduce yoy invests while ORCL stands at 90.97%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
25.00%
We repay more while ORCL is negative at -83.73%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-57.74%
Both yoy lines negative, with ORCL at -71.65%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
2.05%
Buyback growth below 50% of ORCL's 62.78%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.